Skip to main content

Advertisement

Open Peer Review Reports for: Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Jul 2005 Submitted Original manuscript
14 Sep 2005 Reviewed Reviewer Report - Klaas Poelstra
28 Nov 2005 Reviewed Reviewer Report - Ignatius Fong
8 Dec 2005 Author responded Author comments - Evangelos Giamarellos-Bourboulis
Resubmission - Version 2
8 Dec 2005 Submitted Manuscript version 2
13 Jan 2006 Reviewed Reviewer Report - Klaas Poelstra
13 Jan 2006 Reviewed Reviewer Report - Ignatius Fong
24 Jan 2006 Author responded Author comments - Evangelos Giamarellos-Bourboulis
Resubmission - Version 3
24 Jan 2006 Submitted Manuscript version 3
5 Feb 2006 Author responded Author comments - Evangelos Giamarellos-Bourboulis
Resubmission - Version 4
5 Feb 2006 Submitted Manuscript version 4
Publishing
21 Feb 2006 Editorially accepted
21 Feb 2006 Article published 10.1186/1471-2334-6-31

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement